Raffaele Baffa is Chief Medical Officer of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 280,645 shares of TCRT, which is worth approximately $575,322. The most recent transaction as insider was on May 17, 2021, when has been sold 80,645 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 281K
0% 3M change
0% 12M change
Total Value Held $575,322

Raffaele Baffa Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2021
BUY
Grant, award, or other acquisition
-
80,645 Added 22.32%
280,645 Common Stock
RB

Raffaele Baffa

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Track Activities on TCRT